| pubmed-article:19406901 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19406901 | lifeskim:mentions | umls-concept:C0796392 | lld:lifeskim |
| pubmed-article:19406901 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
| pubmed-article:19406901 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
| pubmed-article:19406901 | lifeskim:mentions | umls-concept:C1527249 | lld:lifeskim |
| pubmed-article:19406901 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
| pubmed-article:19406901 | lifeskim:mentions | umls-concept:C1956962 | lld:lifeskim |
| pubmed-article:19406901 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:19406901 | lifeskim:mentions | umls-concept:C0596581 | lld:lifeskim |
| pubmed-article:19406901 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:19406901 | pubmed:dateCreated | 2009-10-28 | lld:pubmed |
| pubmed-article:19406901 | pubmed:abstractText | Bevacizumab significantly improves survival when added to chemotherapy for metastatic colorectal cancer (mCRC). The Bevacizumab Expanded Access Trial (BEAT) evaluated the safety and efficacy of bevacizumab plus first-line chemotherapy in a general cohort of patients with mCRC. | lld:pubmed |
| pubmed-article:19406901 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19406901 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19406901 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19406901 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19406901 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19406901 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19406901 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19406901 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19406901 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19406901 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19406901 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19406901 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19406901 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:19406901 | pubmed:issn | 1569-8041 | lld:pubmed |
| pubmed-article:19406901 | pubmed:author | pubmed-author:RiveraFF | lld:pubmed |
| pubmed-article:19406901 | pubmed:author | pubmed-author:BerrySS | lld:pubmed |
| pubmed-article:19406901 | pubmed:author | pubmed-author:CunninghamDD | lld:pubmed |
| pubmed-article:19406901 | pubmed:author | pubmed-author:PeetersMM | lld:pubmed |
| pubmed-article:19406901 | pubmed:author | pubmed-author:KretzschmarAA | lld:pubmed |
| pubmed-article:19406901 | pubmed:author | pubmed-author:GeorgouliasVV | lld:pubmed |
| pubmed-article:19406901 | pubmed:author | pubmed-author:Van CutsemEE | lld:pubmed |
| pubmed-article:19406901 | pubmed:author | pubmed-author:MichaelMM | lld:pubmed |
| pubmed-article:19406901 | pubmed:author | pubmed-author:BridgewaterJJ | lld:pubmed |
| pubmed-article:19406901 | pubmed:author | pubmed-author:CanonJ-LJL | lld:pubmed |
| pubmed-article:19406901 | pubmed:author | pubmed-author:DiBartolomeoM... | lld:pubmed |
| pubmed-article:19406901 | pubmed:author | pubmed-author:MazierM-AMA | lld:pubmed |
| pubmed-article:19406901 | pubmed:author | pubmed-author:First BEAT... | lld:pubmed |
| pubmed-article:19406901 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19406901 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:19406901 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19406901 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19406901 | pubmed:pagination | 1842-7 | lld:pubmed |
| pubmed-article:19406901 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:19406901 | pubmed:meshHeading | pubmed-meshheading:19406901... | lld:pubmed |
| pubmed-article:19406901 | pubmed:meshHeading | pubmed-meshheading:19406901... | lld:pubmed |
| pubmed-article:19406901 | pubmed:meshHeading | pubmed-meshheading:19406901... | lld:pubmed |
| pubmed-article:19406901 | pubmed:meshHeading | pubmed-meshheading:19406901... | lld:pubmed |
| pubmed-article:19406901 | pubmed:meshHeading | pubmed-meshheading:19406901... | lld:pubmed |
| pubmed-article:19406901 | pubmed:meshHeading | pubmed-meshheading:19406901... | lld:pubmed |
| pubmed-article:19406901 | pubmed:meshHeading | pubmed-meshheading:19406901... | lld:pubmed |
| pubmed-article:19406901 | pubmed:meshHeading | pubmed-meshheading:19406901... | lld:pubmed |
| pubmed-article:19406901 | pubmed:meshHeading | pubmed-meshheading:19406901... | lld:pubmed |
| pubmed-article:19406901 | pubmed:meshHeading | pubmed-meshheading:19406901... | lld:pubmed |
| pubmed-article:19406901 | pubmed:meshHeading | pubmed-meshheading:19406901... | lld:pubmed |
| pubmed-article:19406901 | pubmed:meshHeading | pubmed-meshheading:19406901... | lld:pubmed |
| pubmed-article:19406901 | pubmed:meshHeading | pubmed-meshheading:19406901... | lld:pubmed |
| pubmed-article:19406901 | pubmed:meshHeading | pubmed-meshheading:19406901... | lld:pubmed |
| pubmed-article:19406901 | pubmed:meshHeading | pubmed-meshheading:19406901... | lld:pubmed |
| pubmed-article:19406901 | pubmed:meshHeading | pubmed-meshheading:19406901... | lld:pubmed |
| pubmed-article:19406901 | pubmed:meshHeading | pubmed-meshheading:19406901... | lld:pubmed |
| pubmed-article:19406901 | pubmed:meshHeading | pubmed-meshheading:19406901... | lld:pubmed |
| pubmed-article:19406901 | pubmed:meshHeading | pubmed-meshheading:19406901... | lld:pubmed |
| pubmed-article:19406901 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19406901 | pubmed:articleTitle | Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. | lld:pubmed |
| pubmed-article:19406901 | pubmed:affiliation | University Hospital Gasthuisberg, Leuven, Belgium. eric.vancutsem@uz.kuleuven.ac.be | lld:pubmed |
| pubmed-article:19406901 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19406901 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:19406901 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19406901 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19406901 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19406901 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19406901 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19406901 | lld:pubmed |
